•• Crutch SJ, Schott JM, Rabinovici GD, et al. Consensus classification of posterior cortical atrophy. Alzheimer Dement. 2017;13(8):870–84. https://doi.org/10.1016/j.jalz.2017.01.014. (The first publication of diagnostic criteria that were determined by consensus.)
•• Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol. 1988;45(7):789–93. https://doi.org/10.1001/archneur.1988.00520310107024. (The original (first) description of posterior cortical atrophy syndrome.)
Article PubMed CAS Google Scholar
Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6. https://doi.org/10.1097/XEB.0000000000000050.
Robinson JL, Richardson H, Xie SX, et al. The development and convergence of co-pathologies in Alzheimer’s disease. Brain. 2021;144(3):953–62. https://doi.org/10.1093/brain/awaa438.
Article PubMed PubMed Central Google Scholar
• Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011;10(9):785–96. https://doi.org/10.1016/S1474-4422(11)70156-9. (A systematic study of AD brain bank tissue revealing clinicopathological subtypes that include hippocampal sparing, typical, and limbic predominant that accounted for approximately 25% of cases.)
Article PubMed PubMed Central Google Scholar
Snowden JS, Stopford CL, Julien CL, et al. Cognitive phenotypes in Alzheimer’s disease and genetic risk. Cortex. 2007;43(7):835–45. https://doi.org/10.1016/S0010-9452(08)70683-X.
Alzheimer’s Association. 2022 Alzheimer’s disease facts and figures. Alzheimer Dement. 2022. https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf
• Mapstone M, Steffenella TM, Duffy CJ. A visuospatial variant of mild cognitive impairment: getting lost between aging and AD. Neurology. 2003;60(5):802–8. https://doi.org/10.1212/01.WNL.0000049471.76799.DE. (Use of novel visual motion stimuli to identify visual dysfunction in mild cognitive impairment.)
Schott JM, Crutch SJ. Posterior cortical atrophy. Continuum (Minneap Minn). 2019;25(1):52–75. https://doi.org/10.1212/CON.0000000000000696.
• Schott JM, Crutch SJ, Carrasquillo MM, et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer’s disease. Alzheimers Dement. 2016;12(8):862–71. https://doi.org/10.1016/j.jalz.2016.01.010. (An international multicenter collaborative study to identify risk factors for PCA.)
Article PubMed PubMed Central Google Scholar
Scelsi MA, Napolioni V, Mead S, et al. The differential genetic architecture between posterior cortical atrophy and amnestic Alzheimer’s disease. Alzheimer Dement. 2020;16(S3). https://doi.org/10.1002/alz.038851
Picillo M, Scannapieco S, Iavarone A, Ginevrino M, Valente EM, Barone P. Posterior cortical atrophy phenotype in a GBA N370S mutation carrier: a case report. BMC Neurol. 2021;21(1):17. https://doi.org/10.1186/s12883-020-02023-5.
Article PubMed PubMed Central CAS Google Scholar
Caroppo P, Belin C, Grabli D, et al. Posterior cortical atrophy as an extreme phenotype of GRN mutations. JAMA Neurol. 2015;72(2):224–8. https://doi.org/10.1001/jamaneurol.2014.3308.
Peng G, Liu P, He F, Luo B. Posterior cortical atrophy as a primary clinical phenotype of corticobasal syndrome with a progranulin gene rs5848 TT genotype. Orphanet J Rare Dis. 2016;11:13. https://doi.org/10.1186/s13023-016-0396-0.
Article PubMed PubMed Central Google Scholar
Giunta M, Libri I, Premi E, et al. Clinical and radiological features of posterior cortical atrophy (PCA) in a GRN mutation carrier: a case report. Eur J Neurol. 2021;28(1):344–8. https://doi.org/10.1111/ene.14574.
Article PubMed CAS Google Scholar
Tremolizzo L, Susani E, Mapelli C, et al. First report of PSEN2 mutation presenting as posterior cortical atrophy. Alzheimer Dis Assoc Disord. 2015;29(3):249–51. https://doi.org/10.1097/WAD.0000000000000052.
Li XY, Cui Y, Jing D, et al. Novel PSEN1 and PSEN2 mutations identified in sporadic early-onset Alzheimer disease and posterior cortical atrophy. Alzheimer Dis Assoc Disord. 2021;35(3):208–13. https://doi.org/10.1097/WAD.0000000000000438.
Article PubMed PubMed Central CAS Google Scholar
Isella V, Villa G, Mapelli C, Ferri F, Appollonio IM, Ferrarese C. The neuropsychiatric profile of posterior cortical atrophy. J Geriatr Psychiatry Neurol. 2015;28(2):136–44. https://doi.org/10.1177/0891988714554713.
Suarez-Gonzalez A, Crutch SJ, Franco-Macias E, Gil-Neciga E. Neuropsychiatric symptoms in posterior cortical atrophy and Alzheimer disease. J Geriatr Psychiatry Neurol. 2016;29(2):65–71. https://doi.org/10.1177/0891988715606229.
Article PubMed PubMed Central Google Scholar
Olds JJ, Hills WL, Warner J, et al. Posterior cortical atrophy: characteristics from a clinical data registry. Front Neurol. 2020;11:358. https://doi.org/10.3389/fneur.2020.00358.
Article PubMed PubMed Central Google Scholar
• Yerstein O, Parand L, Liang LJ, Isaac A, Mendez MF. Benson’s disease or posterior cortical atrophy, revisited. J Alzheimers Dis. 2021;82(2):493–502. https://doi.org/10.3233/JAD-210368. (With up to 25 years of clinical follow-up, this is one of only two longitudinal studies to report PCA survival data.)
Article PubMed PubMed Central Google Scholar
Lehmann M, Barnes J, Ridgway GR, et al. Global gray matter changes in posterior cortical atrophy: a serial imaging study. Alzheimers Dement. 2012;8(6):502–12. https://doi.org/10.1016/j.jalz.2011.09.225.
Article PubMed PubMed Central Google Scholar
Migliaccio R, Agosta F, Scola E, et al. Ventral and dorsal visual streams in posterior cortical atrophy: a DT MRI study. Neurobiol Aging. 2012;33(11):2572–84. https://doi.org/10.1016/j.neurobiolaging.2011.12.025.
Article PubMed PubMed Central Google Scholar
Groot C, Yeo BTT, Vogel JW, et al. Latent atrophy factors related to phenotypical variants of posterior cortical atrophy. Neurology. 2020;95(12):e1672–85. https://doi.org/10.1212/WNL.0000000000010362.
Article PubMed PubMed Central CAS Google Scholar
Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. https://doi.org/10.1186/s12874-018-0611-x.
Article PubMed PubMed Central Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178–89. https://doi.org/10.1016/j.jclinepi.2021.03.001.
•• Firth NC, Primativo S, Marinescu RV, et al. Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy. Brain. 2019. https://doi.org/10.1093/brain/awz136. (One of the largest studies to investigate longitudinal profiles in a PCA cohort.)
Article PubMed PubMed Central Google Scholar
Yong K, Rajdev K, Warrington E, Nicholas J, Warren J, Crutch S. A longitudinal investigation of the relationship between crowding and reading: a neurodegenerative approach. Neuropsychologia. 2016;85:127–36. https://doi.org/10.1016/j.neuropsychologia.2016.02.022.
Article PubMed PubMed Central Google Scholar
Whitwell J, Martin PR, Graff-Radford J, et al. Investigating heterogeneity and neuroanatomic correlates of longitudinal clinical decline in atypical Alzheimer disease. Neurology. 2022:98(24). https://doi.org/10.1212/WNL.0000000000200336
Ridha BH, Crutch S, Cutler D, et al. A double-blind placebo-controlled cross-over clinical trial of DONepezil in posterior cortical atrophy due to underlying Alzheimer’s disease: DONIPAD study. Alzheimers Res Ther. 2018;10(1):44. https://doi.org/10.1186/s13195-018-0363-1.
Article PubMed PubMed Central CAS Google Scholar
Paterson RW, Toombs J, Slattery CF, et al. Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis. J Neurol. 2015;262(12):2722–30. https://doi.org/10.1007/s00415-015-7904-3.
Article PubMed CAS Google Scholar
Overman MJ, Drummond N, Butler CR, Ahmed S. Tracking the clinical progression of posterior cortical atrophy: implications for post-diagnostic and therapeutic interventions. J Neurol Neurosurg Psychiatry. 2022;93(6):683–4. https://doi.org/10.1136/jnnp-2021-327501.
Panegyres PK, Goh J, McCarthy M, Campbell AI. The nature and natural history of posterior cortical atrophy syndrome: a variant of early-onset Alzheimer disease. Alzheimer Dis Assoc Disord. 2017;31(4):295–306. https://doi.org/10.1097/WAD.0000000000000207.
Kremer HPH, Hungtington Study Group X. Unified Huntington’s disease rating scale: reliability and consistency. Mov Disord. 1996;11:136–42. https://doi.org/10.1006/urn:nbn:nl:ui:22-2066/23289.
Logsdon RG, Gibbons LE, McCurry SM, Teri L. Quality of life in Alzheimer’s disease: patient and caregiver reports. J Ment Health Aging. 1999;5(1):21–32.
Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med. 2002;64(3):510–9. https://doi.org/10.1097/00006842-200205000-00016.
Marinescu RV, Eshaghi A, Lorenzi M, et al. DIVE: a spatiotemporal progression model of brain pathology in neurodegenerative disorders. Neuroimage. 2019;192:166–77. https://doi.org/10.1016/j.neuroimage.2019.02.053.
Phillips JS, Da Re F, Irwin DJ, et al. Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer’s disease. Brain. 2019;142(6):1701–22. https://doi.org/10.1093/brain/awz091.
Article PubMed PubMed Central Google Scholar
Singh NA, Tosakulwong N, Graff-Radford J, et al. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer’s disease. Alzheimers Dement. 2022. https://doi.org/10.1002/alz.12711.
Phillips JS, Nitchie FJ, Da Re F, et al. Rates of longitudinal change in (18) F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer’s disease. Alzheimers Dement. 2022;18(6):1235–47.
留言 (0)